- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/02 - Drugs for disorders of the nervous system for peripheral neuropathies
Patent holdings for IPC class A61P 25/02
Total number of patents in this class: 2257
10-year publication summary
|
60
|
93
|
124
|
169
|
140
|
173
|
165
|
174
|
166
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
26 |
| Daiichi Sankyo Company, Limited | 1875 |
22 |
| Shionogi & Co., Ltd. | 829 |
21 |
| The Regents of the University of California | 20378 |
19 |
| Osaka University | 3358 |
17 |
| Vertex Pharmaceuticals Incorporated | 1617 |
16 |
| Mitsubishi Tanabe Pharma Corporation | 543 |
15 |
| Grünenthal GmbH | 543 |
14 |
| Kyoto University | 2877 |
14 |
| Bristol-myers Squibb Company | 4810 |
13 |
| Toray Industries, Inc. | 7011 |
12 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3354 |
12 |
| Novartis AG | 10463 |
11 |
| King's College London | 548 |
11 |
| Kinki University | 246 |
11 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 36 |
11 |
| Janssen Pharmaceutica N.V. | 3307 |
10 |
| Pfizer Inc. | 3374 |
10 |
| The Trustees of Columbia University in the City of New York | 3614 |
10 |
| Eurofarma Laboratorios S.A. | 38 |
10 |
| Other owners | 1972 |